Introduction
Bronchial asthma (BA) is a clinical syndrome characterized by the increased responsiveness of bronchoprovocative stimuli with spontaneous fluctuations in the severity of obstruction, and the infiltration of inflammatory cells ( 1) .
The role oflymphokines in the regulation ofimmunoglobulin production and inflammation associated with allergy and bronchial asthma has received considerable attention. Cytokines have a broad range of cell regulatory activities both in vitro and in vivo and play an important role in manyphysiological responses and the pathophysiology of many diseases. Cytokines such as interleukin-5 (IL-5) (2), interleukin-3 (IL-3) (3) and granulocyte/macrophage-colony stimulating factor (GM-CSF) (4) can activate eosinophils in vitro, prolong their survival in culture and render them hypodense. Interferon-y (IFN-y) has also been reported to prolong eosinophil survival in vitro (5) . and GM-CSF (4) have been found to enhance leukotriene C4 (LTC4) generation from eosinophils. In addition, and when cultured with eosinophils were found to enhance their helminthotoxic activity. IL-5 is also a chemoattractant for eosinophils (6) . IL-5 predominate in bronchoalveolar lavage (BAL) samples from atopic patients (7) . It has been reported that eosinophils play an important role in inflammatory responses (1) , suggestive of a relationship between eosinophils and monocytes or lymphocytes through various cytokines in bronchial asthma (8) . In the present study eosinophil viability-enhancing activity (EVEA) was studied in mite-stimulated peripheral blood mononuclear cells (PBMNCs) obtained from mite-sensitive bronchial asthma patients and normal control subjects. Furthermore, we analyzed the EVEA and examined its response to various immunosuppressive drugs.
Eosinophils have been found to release eosinophil cationic protein (ECP) in allergic diseases (9) . Stimulation ofeosinophils with human IgG-or human secretory IgA (hsIgA)-coated Sepharose 4B beads (10) induces the release of proteins, such as eosinophil-derived neurotoxin. Wetreated mite-stimulated culture supernatants with hsIgA-coated Sepharose 4B beads to determine if they would degranulate eosinophils.
yr mean 35.8+7.0; 4 men, 2 women) ( Effect of dexamethasone, cyclosporin A and FK506 Peripheral blood mononuclear cells (0.5x106/ml) from BA patients were cultured with mite (10 jig/ml) and various doses ofdexamethasone, cyclosporin A (CsA) or FK506 in a humidified atmosphere of5% CO2, 95%air at 37°C. After 5 days, cell culture supernatants were transferred to microtubesand centrifuged at 700xg for 5 min. Supernatants for eosinophil survival assay were stored at -20°C until use. To examine the direct effects of dexamethasone, CsA and FK506on eosinophil survival, mite-stimulated ( 1 0 | J.g/ml) PBMNCculture supernatants (25 jLil/well) were spiked with fresh doses of drugs.
Eosinophil purification
After informed consent, 1 00 ml ofheparinized venous blood was obtained from normal control subjects and mild BApatients and sedimented with 6%dextran (Pharmacia Fine Chemicals, Uppsala, Sweden) in 0.9% NaCl at a 5:1 ratio for 45 min at 37°C. The buffy coat was collected and washed twice in Pipes (Sigma) buffer (25 mMPipes, 50 mMNaCl, 5 mMKC1, 25 mM NaOH, 5.4 mMglucose) as previously described (12). The cells were suspended in 2 ml of Percoll (Sigma) with a density of 1.070 g/ml with 5% heat-inactivated DCSand overlayered onto a discontinuous Percoll gradient with the following densities (g/ml): 1.080, 1.085, 1.090, 1.100and 1.120. Percollosmolarity ranged from 290 to 316 mOsm/kg, with a pH of7.3. The cells were centrifuged through the gradient at l ,500xg for 45 min at 4°C using a fixed-angle rotor. Eosinophils were collected from fractions with densities greater than 1.095 g/ml with aperistaltic pump. Eosinophils were washed three times in Pipes buffer and stained with trypan blue and Randolph stain. The cell viability was >98%according to trypan blue dye exclusion, and the purity of the eosinophils was determined using Randolph stain. The purities of the eosinophils for the eosinophil survival assay and degranulation assay were >80%and >85%, respectively. Contaminating cells were shownto be neutrophils. For the eosinophil survival assay, red blood cells were lysed by hypotonic shock. Significant inhibitory effect ofneutrophils on eosinophil survival was not observed at or below 20% of neutrophil contamination (13). The eosinophils were then washed with Hybri-Care medium (American Type Culture Collection, Rockville, MD,USA) and resuspended in Hybri-Care medium containing 10% heat-inactivated DCS, 0.1% human serum albumin (Sigma) , gentamicin (50 |ig/ml) and 2 mML-glutamine (Sigma) .
For the degranulation assay, eosinophils were resuspended in this medium and kept overnight at 4°C.
Eosinophil survival assay Freshly isolated eosinophils (2.5x104/well) were cultured with mite-stimulated and non-stimulated PBMNC culture supernatants (25% v/v) in a humidified atmosphere of5% CO2, 95%air at 37°C in 96-well half-area flat-bottomed tissue culture plates (no. 3696, Costar, Cambridge, MA, USA). For eosinophil survival assay, the final volume was adjusted to 100 |ll1.
Eosinophil viability was determined on day 4. A 10 jixl sample of the culture mediumwas carefully removed from each well and 10 |il of fluorescence diacetate (0.2 mg/ml) in phosphate buffered saline at a 1 :24 ratio was added to the wells. After 15-min culture at 4°C, the number of viable cells showing green fluorescence was counted under a fluorescence microscope. The total number of eosinophils was counted under a light microscope. In preliminary experiments, the number of eosinophils did not change between day 1 and day 4 and neutrophils were spontaneously lysed by day 4 (data not shown). The EVEA of PBMNC culture supernatants was calculated as follows: EVEA= (live eosinophils/total eosinophils) xlOO. Each experiment was performed in duplicate.
Neutralization experiment
Mite-stimulated culture supernatants (25 |il) were reacted with monoclonal antibodies against cytokines (1 Jig/10 jllI) or combinations of antibodies in 96-well half-area flat-bottomed tissue culture plates (Costar) at roomtemperature for 1 hr. For eosinophil survival assay, freshly isolated eosinophils (2.5x 104) were added to each well. Preliminary studies showed that the antibodies inhibited cytokine-induced eosinophil survival in a dose-dependent manner. Antibodies ( 10 jig) against IL-5 , IL-3, GM-CSF and IFN-y completely neutralized rhIL-5 (300 pg), rhIL-3 (200 pg), rhGM-CSF (20 pg) and rhIFN-y (800 IU), respectively. Each antibody was specific for its respective cytokine (data not shown). Isotype-matched monoclonal antibody and the combinations of antibodies did not have any significant inhibitory effect in neutralization experiments (data not shown).
IFN-y measurement
The level of IFN-y in mite-stimulated culture supernatants of BApatients and normal control subjects was measured by an enzyme-linked immunosorbent assay (ELISA) kit (Medgenix Diagnostics, Fleurus, Belgium).
Eosinophil degranulation ofPBMNC culture supernatants Sepharose 4B beads were coated with hsIgA (Accurate Chemical Scientific Corporation, Westbury, NY, USA) as described previously ( 1 0 in a humidified atmosphere of5% CO2, 95%air at 37°C. Plates were centrifuged at l,000xg for 10 min at 4°C. Supernatants were then collected and stored at -20°C until assayed. ECP contents were then measured with an ECP-kit (Pharmacia Fine Chemicals, Uppsala, Sweden).
Statistical analysis
All values are expressed as means±standarderror of the mean(SEM). Differences amonggroups were evaluated by one factorial ANOVA.
Results

Dose-responseand time course
The EVEAin response to mite concentrations of 1 jig/ml and 10 Jig/ml was significantly higher in BA patients than in normal control subjects (p<0.05, p<0.05, respectively; Fig. 1 ). The
EVEAin BApatients was significantly higher at mite concentrations of 1 | Lig/inl and 10 jug/ml than at 0 |ag/ml (p<0.05, p<0.05, respectively). However, the EVEAat 10 JLig/ml was not significantly higher than at 0 jig/ml in normal control subjects. Even at a mite concentration of 0 Jig/ml the EVEAwas somewhat higher in BApatients than in normal control subjects (p<0. 1). EVEAwas dependent on the duration of culture and reached aplateau on day 5 or day 6 (data not shown). Therefore, subsequent experiments were conducted with 1 0 |Hg/ml of mite and a 5-day culture period.
Neutralization experiment Figure 2 shows that anti-IFN-y mAbalone significantly neutralized the EVEAof BA patients and that the EVEA remained practically unchanged in the absence of antibodies Cyclosporin A (10^M) Fig. 4 . The effect of cyclosporin A on eosinophil viability enhancing activity (EVEA). The mite-stimulated EVEAof bronchial asthma patients (n=6) was significantly inhibited at concentrations from 10~7 Mto 10~5 M compared with the EVEAat 0 M(closed circles). In contrast, the direct effect ofcyclosporin A on EVEAat 10~7 M, 10"6 M and 10~5 M was not significant compared with the effect at 0 M(open circles). *p<0.001 ; fp<0.05; significant difference between with and without drug.
Effects of drugs on EVEA Figure 3 shows that the direct effect of dexamethasone was not significant on the EVEAof mite-stimulated culture supernatants between 0 M and 10~8 M, 10~7 M, 10~6 M, 10~5 M, respectively. However, the EVEAof PBMNCsfrom BA patients in the presence of dexamethasone at 1CT8 M, 10~7 M, 10~6 M and 10~5 M was significantly reduced compared with EVEA at 0 M (p<0.05, p<0.001, p<0.001, p<0.001, respectively). Significant inhibition by dexamethasone on the EVEA of mite-stimulated culture supernatants was observed at 10~8 M, 10~7 M, 10~6 M and 10~5 Mofdexamethasone, corresponding to the same concentrations in the direct effect of dexamethasone (p<0.02, p<0.001, p<0.001, p<0.001). CyclosporinA (1(T7 M to 10~5 M) andFK506 (1(T8 Mto 1CT6 M) had effects similar to those of dexamethasone (Figs. 4 and 5) . The effect ofPBMNC culture supernatants on ECPrelease
Eosinophil cationic protein release in the presence of mitestimulated PBMNC culture supernatants was significantly higher in BA patients (569±147 jLXgA) than in normal control subjects . Eosinophil survival assay is a more sensitive method of measuring eosinophil-active cytokines than the ELISA assay (15). Using an eosinophil survival assay we reported previously that it is possible to detect IL-3, IL-5, GM-CSFand IFN-yfrom 1 pg/ml to 100pg/ml(13), 1 pg/mlto 100pg/ml(13),0.1 pg/mlto 10pg/ ml (1 3) and 1 IU/ml to lO IU/ml (our unpublished observation), respectively. In the present study, anti-IFN-y mAbalone significantly inhibited EVEAand we also measured IFN-y by ELISA.
A combination of IL-3, IL-5 and GM-CSFmAbs showed significant inhibition of EVEA,although we could not measure IL-3, IL-5 or GM-CSFusing ELISA because of low sensitivity. However,neutralization experiments using an eosinophil survival assay indicated that IL-3, IL-5, GM-CSF and IFN-y are involved in EVEAand we could detect the amount of IFN-y using ELISA. Furthermore, eosinophil survival assay showed that EVEAmay be produced spontaneously in BApatients, suggesting the existence of activated cytokine-producing cells.
Mosmannand Coffman ( 1 6) reported that mouse TH1 clones produced IL-2, IFN-y, IL-3 and GM-CSF, while TH2 clones produced IL-4, IL-5, IL-6, IL-3 and GM-CSF. Similar findings in the BALsamples from patients with atopic asthma have been reported in humans (17). Ellaurie and coworkers ( 1 8) reported that IFN-y production was much higher in mite-sensitive BA patients than in normal control subjects. It was recently reported that antigen-specific clones established from atopic donors produced . Parronchi and coworkers (20) reported that Dermatophagoides pteronyssinus group (Der Pl)-specific CD4+ T-cell clones produced IL-4 and IL-5 and variable amounts of IL-2, but produced only small amounts of IFN-y. The PBMNCsof the BA patients in the present study appeared to contain two types of clones, similar to mouseTH1 and TH2clones, because mite-stimulated PBMNCs supernatants contained IFN-y, IL-3, IL-5 and GM-CSF. However, high levels of IL-5 in BAL samples (16) PBMNCs in this study may play an important role in the expression of endothelial adhesion molecules (22) and migration of eosinophils from peripheral blood to the lung. In this study, mite-stimulated monocytes may be involved in IFN-y production through tumor necrosis factor-alpha and interleukin 1-alpha (8) .
In the present study, dexamethasone significantly inhibited EVEA.Larsson (23) also observed that dexamethasone at a concentration of 10~6 M, achieved clinically with commonly used steroid dosage regimens (24), markedly reduced T-cell growth factor (TCGF)production. Dexamethasone has been found to specifically inhibit induction of both TCGFand IFNy mRNAin normal lymphocytes (25). Glucocorticoid induces apoptosis in lymphocytes (26). It is thought that inhibition of EVEAmay be due to a steroid-dependent activation of an endonuclease that degrades nuclear DNA(27). Cyclosporin A and FK506 also significantly inhibited EVEA. Reem and Cook (28) 
